Seller record · Telehealth service

RxION Health

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S4, compounding disclosure: The semaglutide and tirzepatide pages name the drugs as compounded and carry no statement that a compounded drug is not FDA-approved. Only the NAD+ page says it is not FDA-approved, and the home page shows a badge reading FDA-Regulated Ingredients. 1 more criterion also fails; see the table below.

At a glance

RxION HealthTelehealth service

6/8criteria passed

Price: Semaglutide $199 a month, tirzepatide $299 (sale; regular $374)
Sells: compounded semaglutide, compounded tirzepatide, and 8 more
FDA letters: None on file

Visit RxION Health See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and tirzepatide, a microdose GLP-1 program, brand Wegovy and Zepbound, and compounded sermorelin, NAD+, glutathione and PT-141, with one, three and six month prices printed on each page. Consultations are provided by a named Texas medical group.

Operating entity RxION Health, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	RxION Health's website; RxION Health's telemedicine page; RxION Health's about page
S2	Prescription gating	PASS	RxION Health's intake page
S3	Pharmacy identification	PASS	RxION Health's telemedicine page
S4	Compounding disclosure	FAIL	RxION Health's website; RxION Health's products page
S5	Analytical documentation	FAIL	RxION Health's products page
S6	Business address	PASS	RxION Health's contact page; RxION Health's shipping policy
S7	Price disclosure	PASS	RxION Health's products page; RxION Health's refund policy
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSEvery patient completes a health questionnaire reviewed by a licensed provider, consultations are provided by Beluga Health, P.A., and the about page names the medical director.Source: RxION Health's website; RxION Health's telemedicine page; RxION Health's about page.

S2PASSThe start button opens an intake that asks for identity and shipping details and states that no payment is taken that day.Source: RxION Health's intake page.

S3PASSThe telemedicine policy names The Pharmacy Hub as the licensed partner pharmacy that may fill and ship the medication, with its telephone number and email address.Source: RxION Health's telemedicine page.

S4FAILThe semaglutide and tirzepatide pages name the drugs as compounded and carry no statement that a compounded drug is not FDA-approved. Only the NAD+ page says it is not FDA-approved, and the home page shows a badge reading FDA-Regulated Ingredients.Source: RxION Health's website; RxION Health's products page.

S5FAILThe product pages say every batch is lab-verified, and no certificate of analysis or lot document is published.Source: RxION Health's products page.

S6PASSRxION Health, Inc. at 6312 S. Fiddlers Green Cir 300E, Greenwood Village, CO 80111, printed on the contact page and in the shipping policy.Source: RxION Health's contact page; RxION Health's shipping policy.

S7PASSCompounded semaglutide at $199 for one month, $381 for three months or $594 for six. Compounded tirzepatide at $299 for one month, printed beside $374 struck through, $997 for three months or $1,797 for six. Microdose semaglutide at $174 a month and microdose tirzepatide at $224, sermorelin at $299, the NAD+ injection at $249, and glutathione and PT-141 at $224. Each price covers the consultation and the medication if prescribed; the refund policy calls the $75 consultation fee non-refundable.Source: RxION Health's products page; RxION Health's refund policy.

S8PASSNo FDA warning letter names RxION Health or RxION Health, Inc., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, microdose semaglutide and tirzepatide with glycine, brand Wegovy, brand Zepbound, sermorelin, NAD+ injection, glutathione, PT-141, testosterone.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione Who sells PT-141

Unpaid link. RxION Health does not pay the site, and nothing is earned when it is used. Funding.

Visit RxION Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.